NYXH
What one share of Nyxoah Sa holds
Surgical and Medical Instruments and Apparatus
Nyxoah Sa’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Profit | −$2.67 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$2.07 |
| Cash and investments | $0.82 |
| Book value | $1.34 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | — | −$0.77 | $0.04 | −$0.47 | — | — |
| 2021 | — | −$1.37 | $0.07 | −$1.33 | — | $6.53 |
| 2022 | — | −$1.27 | $0.04 | −$1.21 | — | $4.98 |
| 2023 | — | −$1.67 | $0.10 | −$1.83 | — | $3.78 |
| 2024 | — | −$1.96 | $0.04 | −$1.67 | — | $3.13 |
| 2025 | — | −$2.67 | $0.02 | −$2.07 | — | $1.34 |